High-dose epiribicin for untreated patients with advanced tumours: a phase I study
- 31 December 1990
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (11-12), 1137-1140
- https://doi.org/10.1016/0277-5379(90)90270-4
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.Journal of Clinical Oncology, 1988
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- Reporting results of cancer treatmentCancer, 1981